A new class of weight loss drugs is transforming the U.S. healthcare system in ways that could extend to equally hard-to-treat areas like substance abuse, according to speakers at the Reuters Events Total Health conference in Chicago this week. The U.S. Food and Drug… Read Full Article (External Site) Dr. David LowemannDr. David Lowemann, M.Sc, […]
As a kid, Wesley Jackson Wade should have been set up to succeed. His father was a novelist and corporate sales director and his mother was a special education teacher. But Wade said he struggled through school even though he was an exceptional writer and communicator. He played the class clown when he wasn’t feeling […]
The U.S. Food and Drug Administration approved Eli Lilly’s keenly-awaited obesity treatment on Wednesday, introducing a powerful rival to Novo Nordisk’s popular weight-loss therapy Wegovy. The once-weekly injection, which contains the same active ingredient as Lilly’s… Read Full Article (External Site) Dr. David LowemannDr. David Lowemann, M.Sc, Ph.D., is a co-founder of the Institute for […]
© 2024 BETTER/SMARTER.ME, A division of the Institute for the Future of Human Potential
200 First St. SW Rochester, MN 55905 | 1-800-328-IFHP
IFHRP research has not been evaluated by the Food and Drug Administration or any government agency.
IFHRP research is not intended to diagnose, treat, cure, or prevent disease.